Program for the Identification of “Actionable” Atrial Fibrillation in the Pharmacy Setting: The PIAAF-Pharmacy Study
To determine the prevalence of “actionable” AF defined as those with (i) previously unrecognized AF and (ii) those with AF but suboptimal anticoagulation therapy through pharmacy-led screening. PIAAF-Pharmacy is a Canadian multicenter study of atrial fibrillation (AF) screening in the community using a novel single-lead ECG device of participants aged 65 and older.
The primary outcome will be to determine the prevalence of “actionable” AF in the community through pharmacy- led screening using a handheld ECG device
Lisa Dolovich, Roopinder Sandhu, Jeff Healey